CTICasesBleomycin-induced Lung Injury
▶ Watch on YouTube — age-restricted, cannot embed here
Imaging findings
The lungs show diffuse ground-glass opacity, predominantly in the upper lobes, and patchy peripheral ground-glass elsewhere. There are areas with developing honeycombing and fibrosis, as well as perrylobular consolidation. Traction bronchiectasis is also present. These findings represent an acute change, as they were absent on a prior CT.
Key takeaways
Bleomycin is a chemotherapeutic agent known to cause drug-induced lung injury. Imaging features can be varied, including ground-glass opacity, organizing pneumonia patterns, and fibrotic changes leading to honeycombing and traction bronchiectasis.
AI-assisted summary — may contain errors. Verify against the source video. Learn more
More from this webinar
- Lupus with Cystic Lung Destruction (mimicking honeycombing)ILD
- Myocarditis / PericarditisInflammatory
- Duchenne Muscular Dystrophy with Dilated CardiomyopathyCongenital
- Allergic Bronchopulmonary Aspergillosis (ABPA)Inflammatory
- Tracheobronchomalacia with Lunate TracheaOther
- Segmental Arterial Medialysis (SAM)Vascular
- Sjogren's Syndrome with NSIP, Follicular Bronchiolitis, and Cysts (mimicking honeycombing)ILD
- SplenosisTrauma
See all cases from February 5, 2016 →
Related ILD cases
- Amiodarone Toxicity Presenting as Organizing Pneumonia
- Pembrolizumab-Associated Organizing Pneumonia (Checkpoint Inhibitor Toxicity)
- Fibrotic Nonspecific Interstitial Pneumonia (NSIP) in Anti-Synthetase Syndrome
- Rapidly Progressive Interstitial Lung Disease in Amyopathic Dermatomyositis
- Lymphangioleiomyomatosis (LAM) Mimicking Alpha-1 Antitrypsin Deficiency
- Alpha-1 Antitrypsin Deficiency Emphysema